Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the European Union
Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) Now Approved in the European Union for Adults with…
Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) Now Approved in the European Union for Adults with…
BDTX-1535, an epidermal growth factor receptor (EGFR) MasterKey inhibitor, demonstrates clinical proof of activity for…
BDTX-1535, an epidermal growth factor receptor (EGFR) MasterKey inhibitor, demonstrates clinical proof of activity for…
Expected FDA approval for KETARX™ (racemic ketamine) via the ANDA pathway in Q1-2024 and commercial…
Expected FDA approval for KETARX™ (racemic ketamine) via the ANDA pathway in Q1-2024 and commercial…
AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s…
AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s…
Complete elimination of viral load in 100% of patients at day 7 vs 6% in…
Complete elimination of viral load in 100% of patients at day 7 vs 6% in…
Underserved residents and businesses in Caroline and Greensville counties to get access to Fios internet…
Underserved residents and businesses in Caroline and Greensville counties to get access to Fios internet…
International Engineering Firm, Jacobs, Partners with Actelis Utilizing its Cyber-Hardened, Rapid Deployment Hybrid Fiber-Copper Networking…
Underserved residents and businesses in Washington and Westmoreland counties to get access to Fios internet…
Underserved residents and businesses in Washington and Westmoreland counties to get access to Fios internet…
Unified view of identity and entitlement risks across Active Directory and Azure AD helps reduce…
Unified view of identity and entitlement risks across Active Directory and Azure AD helps reduce…
Accelerating efficiencies, reducing costs, and maximizing revenue for broadcast stations SAN FRANCISCO, June 27, 2023…
Accelerating efficiencies, reducing costs, and maximizing revenue for broadcast stations SAN FRANCISCO, June 27, 2023…
CULVER CITY, Calif., June 27, 2023 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail”), a…
CULVER CITY, Calif., June 27, 2023 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail”), a…